BIONET (1784.TWO) Earnings Analysis

BIONET (1784.TWO) next reports earnings on 2026-08-19, consensus EPS 0.31 TWD. Last quarter (2026-05-08) it missed with EPS 0.25 TWD vs 0.29 TWD est (-13.8%). It has beaten estimates in 1/5 recent quarters (20%). Trailing P/E 62.47.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does 1784.TWO next report earnings?

Next earnings date2026-08-19
Consensus EPS estimate0.31 TWD
Revenue estimate0.33B

1784.TWO earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-05-080.25 TWD0.29 TWD-13.8%Miss
2026-03-040.29 TWD0.68 TWD-57.4%Miss
2025-08-070.23 TWD0.57 TWD-59.6%Miss
2024-12-310.655 TWD0.4482 TWD+46.1%Beat
2024-09-300.23 TWD0.4202 TWD-45.3%Miss

Beat rate: 1/5 (20%) over reported quarters with consensus data.

1784.TWO valuation and analyst view

Trailing P/E62.47
Trailing EPS45.084 TWD
Price / book0.04
Dividend yield2.34%
Market cap3.06B

Limited or no published sell-side analyst coverage for this symbol.

Related research pages

Frequently asked questions

When is BIONET (1784.TWO)'s next earnings date?

BIONET is next scheduled to report on 2026-08-19, with a consensus EPS estimate of 0.31 TWD and revenue estimate of 0.33B.

Did 1784.TWO beat earnings last quarter?

In its 2026-05-08 report, 1784.TWO posted EPS of 0.25 TWD versus a 0.29 TWD estimate — a miss of 13.8%.

What is 1784.TWO's earnings track record?

Over the last 5 reported quarters with consensus data, 1784.TWO beat estimates 1 times (20%).

What is 1784.TWO's current P/E ratio and EPS?

1784.TWO trades at a trailing P/E of 62.47 on trailing EPS of 45.084235860409144 TWD.

What do analysts rate 1784.TWO?

1784.TWO has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.